688193 仁度生物
按盤價 
26.290 -0.140 (-0.530%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.386 | 0.858 | 3.736 | 25.705 | 33.567 |
| 總資產報酬率 ROA (%) | 0.354 | 0.771 | 3.180 | 18.747 | 24.657 |
| 投入資產回報率 ROIC (%) | 0.381 | 0.844 | 3.639 | 24.148 | 31.911 | 邊際利潤分析 |
| 銷售毛利率 (%) | 80.558 | 81.382 | 65.529 | 74.623 | 75.872 |
| 營業利潤率 (%) | 7.528 | 3.310 | 9.053 | 24.696 | 27.664 |
| 息稅前利潤/營業總收入 (%) | 1.112 | -2.053 | 7.333 | 24.277 | 28.072 |
| 淨利潤/營業總收入 (%) | 8.265 | 5.024 | 7.679 | 22.107 | 24.560 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 31.875 | -375.331 | 50.140 | 90.092 | 90.158 |
| 價值變動淨收益/利潤總額(%) | 47.285 | 159.276 | 34.935 | 1.676 | 1.537 |
| 營業外收支淨額/利潤總額(%) | -0.017 | -14.271 | -3.094 | 0.350 | 1.582 | 償債能力分析 |
| 流動比率 (X) | 12.227 | 11.462 | 10.188 | 4.261 | 2.990 |
| 速動比率 (X) | 11.855 | 11.097 | 9.892 | 3.969 | 2.777 |
| 資產負債率 (%) | 8.143 | 8.720 | 11.696 | 23.999 | 30.810 |
| 帶息債務/全部投入資本 (%) | -0.189 | -0.095 | -1.251 | -3.687 | 0.124 |
| 股東權益/帶息債務 (%) | -52,432.223 | -104,367.986 | -7,834.932 | -2,590.861 | 74,087.456 |
| 股東權益/負債合計 (%) | 1,128.013 | 1,046.754 | 754.992 | 316.691 | 224.568 |
| 利息保障倍數 (X) | -0.173 | 0.415 | -5.064 | -48.026 | -774.568 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 147.014 | 198.893 | 94.892 | 58.176 | 43.138 |
| 存貨周轉天數 (天) | 287.260 | 334.512 | 81.934 | 86.706 | 80.759 |
| 備註： | 即時報價更新時間為 28/06/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
